Massachusetts biotechnology companies announced nearly $780 million in new funding during the week before the J.P. Morgan ...
Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicontm peptide platform to drug historically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback